North America Pharmaceutical Continuous Manufacturing 麻豆原创 2020-2030 by Product (Integrated, Semi-Continuous, Controls & Software), Application (End Product, API), End User, and Country: Trend Forecast and Growth Opportunity

Publication ID:

GRM0920042

Publication Date:

September 28, 2020

Pages:

106

Publisher:

Grace 麻豆原创 Data

Countries:

North America [1]

USD 2,600.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

North America pharmaceutical continuous manufacturing market is expected to grow by 9.5% annually in the forecast period and reach $851.9 million by 2030 driven by advantages offered by continuous manufacturing process such as cost saving and improved productivity.
Highlighted with 25 tables and 39 figures, this 106-page report 鈥淣orth America Pharmaceutical Continuous Manufacturing 麻豆原创 2020-2030 by Product (Integrated, Semi-Continuous, Controls & Software), Application (End Product, API), End User, and Country: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire North America pharmaceutical continuous manufacturing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
鈥� 麻豆原创 Structure
鈥� Growth Drivers
鈥� Restraints and Challenges
鈥� Emerging Product Trends & 麻豆原创 Opportunities
鈥� Porter鈥檚 Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America pharmaceutical continuous manufacturing market in every aspect of the classification from perspectives of Product, Application, End User, and Country.

Based on Product, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Integrated Continuous Systems
Semi-Continuous Systems
鈥� Continuous Granulators
鈥� Continuous Blenders
鈥� Continuous Compressors
鈥� Continuous Coaters
鈥� Continuous Dryers
鈥� Other Semi-Continuous Systems
Controls & Software

Based on Application, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
End Product Manufacturing
鈥� Solid Dosage Manufacturing
鈥� Liquid Dosage Manufacturing
API Manufacturing

Based on End User, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
鈥� Pharmaceutical Companies
鈥� Contract Manufacturing Organizations
鈥� Research Organizations and Institutes
鈥� Other End Users

Geographically, the following national/local markets are fully investigated:
鈥� U.S.
鈥� Canada
鈥� Mexico
Detailed analysis and 2019-2030 annual revenue are available for each key national market. The breakdown of key national markets by Product, Technology, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in North America pharmaceutical continuous manufacturing market are assayed quantitatively and qualitatively through GMD鈥檚 Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
ACG Group
Alexanderwerk
Baker Perkins Ltd.
Coperion GmbH
Fette Compacting
Freund-vector Corporation
GEA Group AG
Gebr眉der L枚dige Maschinenbau GmbH
Gericke AG
Glatt GmbH
Hosokawa Micron Corporation
Korsch AG
Leistritz AG
Munson Machinery Company, Inc.
Powrex Corp
Scott Equipment Company
Sturtevant, Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents:

1 Introduction 6
1.1 Industry Definition and Research Scope 6
1.1.1 Industry Definition 6
1.1.2 Research Scope 7
1.2 Research Methodology 10
1.2.1 Overview of 麻豆原创 Research Methodology 10
1.2.2 麻豆原创 Assumption 11
1.2.3 Secondary Data 11
1.2.4 Primary Data 11
1.2.5 Data Filtration and Model Design 13
1.2.6 麻豆原创 Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 麻豆原创 Overview and Dynamics 18
2.1 麻豆原创 Size and Forecast 18
2.1.1 Impact of COVID-19 on World Economy 19
2.1.2 Impact of COVID-19 on the 麻豆原创 22
2.2 Major Growth Drivers 24
2.3 麻豆原创 Restraints and Challenges 27
2.4 Emerging Opportunities and 麻豆原创 Trends 30
2.5 Porter鈥檚 Fiver Forces Analysis 34
3 Segmentation of North America 麻豆原创 by Product 40
3.1 麻豆原创 Overview by Product 40
3.2 Integrated Continuous Systems 42
3.3 Semi-Continuous Systems 43
3.3.1 Continuous Granulators 45
3.3.2 Continuous Blenders 46
3.3.3 Continuous Compressors 47
3.3.4 Continuous Coaters 48
3.3.5 Continuous Dryers 49
3.3.6 Other Semi-Continuous Systems 50
3.4 Controls & Software 51
4 Segmentation of North America 麻豆原创 by Application 52
4.1 麻豆原创 Overview by Application 52
4.2 End Product Manufacturing 54
4.2.1 Solid Dosage Manufacturing 56
4.2.2 Liquid Dosage Manufacturing 57
4.3 API Manufacturing 58
5 Segmentation of North America 麻豆原创 by End User 60
5.1 麻豆原创 Overview by End User 60
5.2 Pharmaceutical Companies 62
5.3 Contract Manufacturing Organizations 63
5.4 Research Organizations and Institutes 64
5.5 Other End Users 65
6 North America 麻豆原创 2019-2030 by Country 66
6.1 Overview of North America 麻豆原创 66
6.2 U.S. 69
6.3 Canada 73
6.4 Mexico 75
7 Competitive Landscape 77
7.1 Overview of Key Vendors 77
7.2 New Product Launch, Partnership, Investment, and M&A 80
7.3 Company Profiles 81
ACG Group 81
Alexanderwerk 83
Baker Perkins Ltd. 84
Coperion GmbH 85
Fette Compacting 86
Freund-vector Corporation 87
GEA Group AG 88
Gebr眉der L枚dige Maschinenbau GmbH 89
Gericke AG 90
Glatt GmbH 91
Hosokawa Micron Corporation 92
Korsch AG 93
Leistritz AG 94
Munson Machinery Company, Inc. 95
Powrex Corp 96
Scott Equipment Company 97
Sturtevant, Inc. 98
Thermo Fisher Scientific Inc. 99
8 Investing in North America 麻豆原创: Risk Assessment and Management 100
8.1 Risk Evaluation of North America 麻豆原创 100
8.2 Critical Success Factors (CSFs) 103
Related Reports and Products 106

Companies Mentioned:

Key Players (this may not be a complete list and extra companies can be added upon request):
ACG Group
Alexanderwerk
Baker Perkins Ltd.
Coperion GmbH
Fette Compacting
Freund-vector Corporation
GEA Group AG
Gebr眉der L枚dige Maschinenbau GmbH
Gericke AG
Glatt GmbH
Hosokawa Micron Corporation
Korsch AG
Leistritz AG
Munson Machinery Company, Inc.
Powrex Corp
Scott Equipment Company
Sturtevant, Inc.
Thermo Fisher Scientific Inc.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.